Table 3:
Lung cancer genotype | +erlotinib exposure | No erlotinib exposure | +platinum exposure | No platinum exposure |
---|---|---|---|---|
EGFR-mutated (N = 77) | 70 | 7 | 27 | 50 |
EGFR wild type (N = 511) | 153 | 358 | 249 | 262 |
Lung cancer genotype | +erlotinib exposure | No erlotinib exposure | +platinum exposure | No platinum exposure |
---|---|---|---|---|
EGFR-mutated (N = 77) | 70 | 7 | 27 | 50 |
EGFR wild type (N = 511) | 153 | 358 | 249 | 262 |